About Switch Bioworks
Switch Bioworks is a private company based in San Carlos, California, incorporated in 2022 in Delaware. It has reported $22,575,660 raised in one offering on Form D since September 2024. Its chief executive is Tim Schnabel.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 21, 2024 | Sep 5, 2024 | $22,575,660of $23.5M target | 22 | $1.0M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Switch Bioworks's Form D filed Sep 5, 2024.